Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
Primaquine is the only available antimalarial drug that kills dormant liver stages of Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse ('radical cure'). It is also the only generally available antimalarial that rapidly sterilises mature P. falciparum game...
Main Authors: | Judith Recht, Elizabeth A Ashley, Nicholas J White |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-04-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5908060?pdf=render |
Similar Items
-
Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal
by: Prakash Ghimire, et al.
Published: (2017-05-01) -
Glucose-6-phosphate dehydrogenase deficiency and the use of primaquine: top-down and bottom-up estimation of professional costs
by: Henry Maia Peixoto, et al.
Published: (2017-10-01) -
Glucose 6-phosphate dehydrogenase on indian piaroas in malaria-endemic area.
by: Gilberto Antonio Bastidas-Pacheco, et al.
Published: (2017-01-01) -
Frequency of malaria and glucose-6-phosphate dehydrogenase deficiency in Tajikistan
by: Saipphudin Karimov, et al.
Published: (2006-06-01) -
Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria
by: James A Watson, et al.
Published: (2019-01-01)